Basic and Clinical Science

eToolkit
July 10, 2018

Lopinavir/ritonavir (LPV/r) pellets are a new formulation of a pediatric HIV medicine. The LPV/r Pellet Toolkit provides information on how to implement rollout of LPV/r pellets into the national health care system in the Rollout Planning and Management section.

Resource
July 5, 2018

Evidence regarding potential adverse neuropsychiatric effects of efavirenz is conflicting, and data from sub-Saharan Africa, where 70% of persons living with HIV (PLHIV) reside and efavirenz is used as first-line therapy, are limited. The objective of this study was to estimate associations betwe

News
July 5, 2018

Treatment with the antiretroviral drug efavirenz did not increase the risk of depressive symptoms or suicidal thoughts in adults living with HIV in Uganda when compared to nevirapine-based treatment, a prospective cohort study published in Annals of Internal Medicine reports.

Resource
June 26, 2018

The Southern Africa HIV and AIDS Regional Exchange (SHARE) is pleased to present the third issue of the project’s research digest.

Resource
June 26, 2018

This article is featured in the SHARE Research Digest. Click here to learn more.

Resource
June 26, 2018

This article is featured in the SHARE Research Digest. Click here to learn more.

Resource
June 13, 2018

HIV acquisition during pregnancy and breastfeeding significantly contributes toward paediatric HIV infection; however, little is known about risk behaviours in HIV-uninfected pregnant and postpartum women.